Skip Navigation


Japanese Journal of Clinical Oncology Advance Access originally published online on May 6, 2005
Japanese Journal of Clinical Oncology 2005 35(5):274-279; doi:10.1093/jjco/hyi073
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
35/5/274    most recent
hyi073v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Hosono, T.
Right arrow Articles by Sugiyama, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hosono, T.
Right arrow Articles by Sugiyama, Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© 2005 Foundation for Promotion of Cancer Research


Case Report

Primary Pulmonary Synovial Sarcoma Confirmed by Molecular Detection of SYT–SSX1 Fusion Gene Transcripts: a Case Report and Review of the Literature

Tatsuya Hosono1, Mitsugu Hironaka2, Akira Kobayashi1, Hideaki Yamasawa1, Masashi Bando1, Shoji Ohno1, Yasunori Sohara3 and Yukihiko Sugiyama1

1 Division of Pulmonary Medicine, Department of Medicine, 2 Department of Pathology and 3 Department of Thoracic Surgery, Jichi Medical School, Kawachi-gun, Tochigi, Japan

For reprints and all correspondence: Tatsuya Hosono, Division of Pulmonary Medicine, Department of Medicine, Jichi Medical School, 3311-1, Minamikawachi-machi, Kawachi-gun, Tochigi 329-0498, Japan. E-mail: kokyu2{at}jichi.ac.jp

Received August 12, 2004; accepted November 20, 2004

This is a case report of a rare patient with primary pulmonary synovial sarcoma. The patient was a 58-year-old woman who presented with a well-defined giant mass in the right lower field on a chest radiograph. A malignant pulmonary tumor was suspected and consequently a right middle and lower lobectomy was performed. Grossly, the tumor measured 10 x 8 x 7 cm, was whitish-yellow in color and friable with hemorrhage. Histologically, the tumor showed a dense proliferation of spindle cells. In some areas, a herringbone-like pattern with coagulation necrosis of large size was noted. Immunohistochemically, the tumor cells were focally positive for cytokeratin and epithelial membrane antigen (EMA). As these features suggested a monophasic synovial sarcoma, we looked for the presence of SYT–SSX fusion gene transcripts using RNA samples from the paraffin-embedded tissue. A reverse transcription–polymerase chain reaction (RT–PCR) amplified a single 118 bp fragment characteristic of the SYT–SSX1 fusion gene transcripts. As no tumor was found at other sites, it was diagnosed as primary pulmonary synovial sarcoma. Molecular testing proved to be very helpful or necessary when monophasic spindle cell synovial sarcoma was recognized in uncommon/unexpected sites. In our review of primary pulmonary synovial sarcomas confirmed by molecular detection of SYT–SSX fusion gene transcripts, the SYT–SSX2 fusion protein expression correlates with poorer prognosis. This is in contrast to the association between the SYT–SSX1 fusion protein expression and poorer prognosis in soft tissue synovial sarcomas.

Key Words: primary pulmonary synovial sarcoma • spindle cell tumor • immunohistochemistry • SYT–SSX fusion gene transcripts


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.